Molecular investigation of methicillin-resistant staphylococcus aureus isolates from blood: USA600 emerges as the major type by Goudarzi, M. et al.
 Original Article 
 
Molecular investigation of methicillin-resistant staphylococcus aureus 
isolates from blood: USA600 emerges as the major type 
 
Mehdi Goudarzi1, Fattaneh Sabzehali1, Mohsen Heidary2, Hadi Azimi3, Hossein Goudarzi1 
 
1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
2 Department of Medical Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran 
3 Department of English Language Teaching, School of Medicine, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran 
 
Abstract 
Introduction: The widespread emergence of methicillin-resistant Staphylococcus aureus is turning into a real worry in public health. The goals 
of the present study were to identify resistance and virulence encoding genes and molecular characteristics of methicillin-resistant S. aureus 
bloodstream isolates. 
Methodology: A cross-sectional study was conducted on 84 S. aureus bloodstream isolates during a 10-month period. To evaluate antibiotic 
susceptibility of the isolates, we used Kirby-Bauer disk diffusion method. In addition, the prevalence of antimicrobial resistance and toxins 
genes was assessed using polymerase chain reaction. Isolates were typed according to polymorphisms seven housekeeping genes by MLST.  
Results: All the isolates were resistant to methicillin. The most prevalent resistance gene was mecA gene (100%) followed by tetM (57.1%), 
aac (6΄)-Ie/aph (2˝) (53.6%), ant (4΄)-Ia (46.4%), ermA (45.2%), msrA (35.7%), msrB (33.3%), aph (3΄)-IIIa (33.3%), ermB (31%), ermC 
(16.7%), and mupA (14.3%) genes. The presence of toxin encoding genes tst, pvl, eta, and etb were detected in 25%, 14.3%, 3.6% and 3.6%, 
respectively. The isolates were classified into five different sequence types: ST45 (29.8%), ST239 (27.4%), ST858 (21.4%), ST22 (17.8%), 
and ST59 (3.6%). All the high-level mupirocin-resistant (HLMUPR) strains belonged to ST239, while the low-level mupirocin resistant 
(LLMUPR) strains belonged to ST22 (13%) and ST239 (6%). 
Conclusions: To the best of our knowledge, the present study is the first report of ST59 in MRSA bloodstream isolates in Iran. Our data 
demonstrated the need for thorough epidemiological monitoring to detect emergence and dissemination of MDR- MRSA types in our hospitals. 
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Introduction 
Methicillin-resistant Staphylococcus aureus 
(MRSA), which is a major global cause of infection in 
both community and hospital, accounts for a broad 
range of serious human infections ranging from skin 
infections to sever infections, including bacteremia [1]. 
According to the literature, compared with non-
invasive MRSA infections, higher mortality rate is 
reported in cases with invasive infections due to MRSA 
[2]. Although different STs have been found to 
predominate in a variety of geographical regions, one of 
the most prevalent sequence types (STs) is USA600 or 
ST45. The first USA600 strain was reported in some 
European countries such as Germany and the 
Netherlands. Since then, numerous surveillance studies 
have revealed a steady increase in the incidence of this 
type in the United States and Canada [2, 3]. According 
to the published data, reported mortality rates among 
patients with MRSA bloodstream infections (BSIs) 
were found to be 20 to 30%. Recent studies have 
reported mortality rates of 60% for patients with MRSA 
BSIs caused by the USA600, suggesting remarkable 
ability of this pathogen to produce virulence factors [2-
4]. The increasing prevalence of MRSA infections and 
its ability to spread in hospitals and health care facilities 
is becoming a major challenge for infection control. 
During the past years, the widespread use of antibiotics 
has led to the emergence and dissemination of invasive 
MRSA strains that systematically harbor multi-
resistance genes and cause failure treatment [5-7]. In 
addition to mecA gene, the emergence of co-existence 
of genes encoding resistance to other antibiotics is the 
new concern, along with the particular concern of 
invasive bloodstream infections [8-11]. A major 
concern with managing MRSA infections in patients 
with blood stream infection is the lack of awareness 
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about the molecular types and antibiotic resistance 
pattern of this bacterium either phenotypically or 
genotypically [1]. Molecular typing methods have been 
developed to track MRSA isolates among which Multi-
Locus Sequence Typing (MLST) technique, with its 
high discriminatory abilities, has been introduced as an 
effective method for typing MRSA strains [12,13]. 
With regards to the lack of sufficient information about 
molecular characterization of MRSA strains isolated 
from blood infection, the present study was conducted 
to understand phenotypic and genotypic resistance 
pattern and to identify STs of MRSA obtained from 
patients with bacteremia in Tehran, Iran. 
 
Methodology 
Study design and population 
In the current cross-sectional study, we investigated 
84 MRSA isolates, recovered over a 10-month period 
from November 2016 to August 2017, from patients 
referring to 12 medical centers located in different areas 
of Tehran (capital city of Iran). The frequency of 
MRSA isolated from studied hospitals in Tehran was as 
following; 12 isolates (14.3%) from hospital A, 12 
isolates from hospital C (14.3%), 11 isolates from 
hospital G (13.1%), 10 isolates from hospital I (11.9%), 
9 isolates from hospital E (10.7%), 8 isolates (9.5%) 
from hospital B, 6 isolates (7.1%) from hospital D, 5 
isolates (5.9%) from hospital H, 4 isolates (4.8%) from 
hospital J, 3 isolates (3.6%) from hospital F, 3 isolates 
(3.6%) from hospital K and one isolate (1.2%) from 
hospital L. One isolate per patient was included in the 
study and duplicate samples were excluded. The study 
was approved by the Ethics Committee at Shahid 
Beheshti University of Medical Sciences, Tehran, Iran 
(IR.SBMU. MSP.REC.1396.2). Blood cultures 
obtained from patients with suspected sepsis so as to 
order to identify S. aureus were processed using 
standard microbiological procedures including colony 
morphology on blood agar, Gram-stain microscopy, b-
hemolysis on 5% sheep blood agar, growth on mannitol 
salt agar, and giving positive results for catalase, 
coagulase, and DNase tests. Isolates were confirmed as 
S. aureus via detecting the presence of the femA and 
nucA genes (encoding peptidyl transferase and 
thermostable nuclease, respectively) using PCR [5,14]. 
 
Antimicrobial susceptibility testing (AST), DNA 
extraction, and MRSA screening 
Antibiotic susceptibility to ampicillin (AP 10 µg), 
ciprofloxacin (CIP 5 µg), tetracyclin (T 30 µg), 
erythromycin (E 15 µg), clindamycin (CD 2 µg), 
linezolid (LZD 30 µg), penicillin (PG 10 µg), 
teicoplanin (TEC 30 µg), gentamicin (GM 10 µg), and 
trimethoprim- sulfamethoxazole (TS 2.5 µg) was 
determined using Kirby Bauer disk diffusion. The 
results were interpreted according to the 
recommendations of the Clinical Laboratory Standard 
Institute (CLSI) [15]. The Minimum inhibitory 
concentration (MIC) for vancomycin (VA), daptomycin 
(DPC), rifampin (RI), and mupirocin (MU) (Sigma-
Aldrich, St. Louis, Mo, USA) were determined using 
micro-broth dilution method. According to the CLSI 
guidelines the MIC breakpoints for vancomycin were 
defined as follows: susceptible, ≤ 2 µg/mL; 
intermediate, 4–8 µg/mL; and resistant, ≥ 16 µg/mL. 
Strains were considered to demonstrate low-level 
mupirocin resistance (LLMUPR) if the MIC value was 
between 8-256 µg/mL and high-level mupirocin 
resistance (HLMUPR) if the MIC value was ≥ 512 
µg/mL. For daptomycin, culture media was 
supplemented with Ca2+ to a final concentration of 50 
µg/mL and strains were reported as sensitive to 
daptomycin if the MIC value was ≤ 1 µg/mL. For 
rifampin, the MIC values ≤ 1 µg/mL was considered as 
susceptible and MIC values ˃ 4 µg/mL was considered 
as resistant. The ranges of MIC value used for 
antimicrobial agents were including: vancomycin 0.125 
to 16 µg/mL; daptomycin 0.125 to 2.0 μg/mL; rifampin 
0.004 to 16 µg/mL and mupirocin 0.5 to ≥ 512 µg/mL. 
All antibiotic disks used in the present study were 
supplied by Mast, UK. S. aureus ATCC25923 and 
ATCC 29213, as standard reference strains, were 
employed in every test run. Genomic DNA was 
extracted using the commercial kit InstaGene Matrix 
(BioRad, Hercules co., CA, USA). MRSA isolates were 
screened with cefoxitin disc (30 µg) and oxacillin disc 
(1µg) and confirmed to presence the mecA gene using 
PCR [7,15]. 
 
Detection of resistance and toxin encoding genes 
The genes encoding the resistance (vanA, vanB, 
mecA, mupA, ermA, ermB, ermC, msrA, msrB, tetM, ant 
(4΄)-Ia, aac (6΄)-Ie/aph (2˝), aph (3΄)-IIIa), and toxin 
(etb, eta, pvl, tst) were targeted via PCR using specific 
primers [7,9]. 
 
Multilocus Sequence Typing (MLST) 
MLST was performed on isolates based on seven 
housekeeping genes (arcC, aroE, glpF, gmK, pta, tpiA, 
and yqiL) as described by Enright et al. [13] Sequence 
type (ST) of each isolate was determined by comparing 
the sequences at each locus with those of the known 
alleles in the S. aureus MLST database 
(http://www.mlst.net/). 
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Results 
A total of 84 S. aureus strains isolated from BSI 
were investigated during the 10-month study period. All 
the isolates were found to be MRSA. The results of AST 
showed resistance to most of the antibiotics, including 
ampicillin (89.3%), ciprofloxacin (67.9%), tetracycline 
(77.4%), gentamicin (58.3%), erythromycin (53.6%), 
clindamycin (35.7%), mupirocin (33.3%), 
trimethoprim-sulfamethoxazole (31%), and rifampin 
(21.4%). Resistance to linezolid, teicoplanin, 
vancomycin, and daptomycin was not found among the 
tested isolates. Based on the micro-broth dilution 
method, isolates were inhibited by vancomycin at 
similar MIC50 and MIC90 1 µg/ml. The MIC50 and 
MIC90 values for daptomycin were found to be 0.25 
µg/mL and 0.5 µg/mL, respectively. Of the 28 
mupirocin resistant MRSA isolates, 12 (14.3%) isolated 
carry mupA gene and were confirmed as HLMUPR 
strains. The predominant resistance profile among 
MDR isolates included a resistance profile to six 
antibiotics (56%) followed by seven antibiotics (33.3%) 
and five antibiotics (2.4%), simultaneously. Seven 
isolates were resistant to one antibiotic (8.3%). With 
regards to the resistance genes, the most prevalent was 
Table 1. Molecular characterization of MRSA strains isolated from BSI. 
Molecular 
types 
Toxin profile 
(No;%) 
Antibiotic resistance gene profile 
(No;%) 
Hospitals 
(No;%) 
Antibiotic resistance profile 
(No;%) 
No (%) 
ST45 - 
mecA (25; 100), aac(6΄)-Ie/aph(2˝ 
) (20; 80), ant(4΄)-Ia (18; 72), 
aph(3΄)-IIIa (12; 48), tetM (12; 
48), ermA (10; 40), ermB (9; 36), 
ermC (8; 32), msrA (7; 28), msrB 
(5; 20), 
A (4; 16), B (2; 8), 
C (5; 20), D (3; 12), 
E (2; 8), G (4; 16), I 
(3; 12), J (2; 8) 
PG, AP, CIP, GM, T, TS (10; 
40) 
PG, AP, T, E, CIP, GM (8; 32) 
PG, AP, CIP, T, GM, RI (5; 20) 
PG, E, CD, GM, RI (2; 8) 
25 (29.8) 
ST239 
tst (12; 52.2), eta 
(3; 13), etb (2; 
8.7) 
mecA (23; 100), msrA (18; 78.3), 
ermA (15; 65.2), msrB(14; 60.9), 
ant(4΄)-Ia (12; 52.2), mupA (12; 
52.2), tetM (12; 52.2), aph(3΄)-IIIa 
(7; 30.4), ermB (7; 30.4), aac(6΄)-
Ie/aph(2˝)(6; 26.1) 
B (1; 4.3), C (3; 
13.1), D (2; 8.7), E 
(3; 13.1), F (2; 8.7), 
G (3; 13.1), H (2; 
8.7), I (5; 21.7), J 
(1; 4.3), K (1; 4.3) 
PG, AP, T, E, CD, TS, MUP 
(12; 52.2) 
PG, AP, CIP, GM, T, TS (4; 
17.4) 
PG, AP, CIP, E, CD, MUP, RI 
(5; 21.7) 
PG, AP, CIP, T, E, GM (2; 8.7) 
23 (27.4) 
ST585 
tst (9; 50), etb (1; 
5.6) 
mecA(18; 100), tetM (15; 83.3), 
aac(6΄)-Ie/aph(2˝) (14; 77.8), 
aph(3΄)-IIIa (9; 50), ant(4΄)-Ia (8; 
44.4), ermB (6; 33.3), ermA (5; 
27.8), msrA(5; 29.4), msrB(4; 
22.2), ermC (3; 16.7) 
A (3; 16.6), B (3; 
16.6), C (2; 11.1), E 
(2; 11.1), F (1; 5.6), 
G (2; 11.1), H (1; 
5.6), I (2; 11.1), J 
(1; 5.6), L (1; 5.6) 
PG, AP, CIP, T, E, GM (5; 
27.8) 
PG, AP, CIP, GM, T, TS (10; 
55.6) 
PG (3; 16.6) 
18 (21.4) 
ST22 pvl (9; 60) 
mecA (15; 100), tetM (7; 46.7), 
ermA (6; 40), msrB (5; 33.3), ermB 
(4;26.7), ermC (3; 20), ant(4΄)-Ia 
(1; 6.7) 
A (4; 26.7), B (2; 
13.3), C (2; 13.3), D 
(1; 6.7), E (2; 13.3), 
G (2; 13.3), K (2; 
13.3) 
PG, AP, T, E, CD, TS, MUP (6; 
40) 
PG, AP, CIP, E, CD, MUP, RI 
(5; 33.3) 
P (4; 26.7) 
15 (17.8) 
ST59 pvl (3; 100) 
mecA(3; 100), tetM (3; 100), ermA 
(2; 66.7) 
A (1; 33.3), H (2. 
66.7) 
PG, AP, CIP, GM, T, TS (2; 
66.7) 
PG, AP, CIP, T, GM, RI (1; 
33.3) 
3 (3.6) 
PG, penicillin; AP, ampicillin; CD, clindamycin; E, erythromycin; GM, gentamicin; MUP, mupirocin; RI, rifampicin; T, tetracycline; CIP, ciprofloxacin; TS, 
trimethoprim- sulfamethoxazole. 
Figure 1. Detection of resistance genes of MRSA strains 
isolated from BSI. 
Lane M, 100-bp DNA ladder (Fermentas, London, UK); lane 1 ant(4΄)-
Ia, lane 2 aac(6΄)-Ie/aph(2˝), lane 3 aph(3΄)-IIIa, lane 4 ermA, lane 5 
ermB, lane 6 ermC, lane 7 msrA, lane 8 msrB, lan 9 mupA, lane 10 tetM. 
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mecA gene (84; 100%) followed by tetM (48; 57.1%), 
aac (6΄)-Ie/aph (2˝) (45; 53.6%), ant (4΄)-Ia (39; 
46.4%), ermA (38; 45.2%), msrA (30; 35.7%), msrB 
(28; 33.3%), aph (3΄)-IIIa (28; 33.3%), ermB (26; 
31%), ermC (14; 16.7%), and mupA (12; 14.3%) genes 
(Figure 1). Toxin analysis revealed that tst gene was the 
most frequent toxin genes among tested isolates (21; 
25%) followed by pvl (12; 14.3%), eta (3; 3.6%), and 
etb (3; 3.6%), respectively. Using MLST technique, the 
strains were classified into five different sequence types 
(STs) as follows: ST45 (25 strains; 29.8%), ST239 (23 
strains; 27.4%), ST858 (18 strains; 21.4%), ST22 (15 
strains; 17.8%), and ST59 (3 strains; 3.6%). The results 
of distribution of various STs in 84 MRSA isolated 
from BSIs among 12 medical centers in Tehran are 
presented in Table 1. The overall prevalence of 
mupirocin resistance was found to be 33.3% using MIC 
out of which 12 (14.3%) and 16 (19%) were HLMUPR 
and LLMUPR, respectively. All the HLMUPR-MRSA 
strains belonged to ST239. ST22 was the predominant 
type observed among LLMUPR-MRSA strains (13 %) 
followed by ST239 (6%). 
 
Discussion 
The present study reports on several important 
findings in relation to molecular typing of MRSA 
strains isolated from BSI, including detection of ST45 
as the most predominant type and high prevalence of 
mupirocin resistance (33.3%), which was distributed 
among ST239 and ST22. Meanwhile, we reported ST59 
the first time in Iran for although at a low frequency 
(3.6%).  
In contrast with a study conducted in the Iran, which 
reported low frequency of ST45 (4%) in MRSA strains 
isolated from patients with bacteremia [1], in the 
present study, we observed a high frequency of the 
ST45 (29.8%) among MRSA strains isolated from 
BSIs. These findings may reflect a true increase in the 
prevalence of ST45 in Iran. The study showed that none 
of the ST45 isolates were susceptible to gentamycin and 
penicillin while 60%, 40%, and 8% were susceptible to 
trimethoprim- sulfamethoxazole, erythromycin, and 
clindamycin respectively. These findings are in contrast 
to those reported in Moore et al’s who reported low 
frequency of resistance to gentamycin (25%) among 
ST45 strains while it was found that all the isolates were 
resistant to erythromycin and clindamycin [2]. 
Variability in resistance and toxin encoding genes 
within ST45 strains were previously reported by several 
investigators [4,16]. The resistance gene profiles of the 
isolates have shown that the overwhelming majority of 
these isolates carried aac(6΄)-Ie/aph(2˝)(80%), and 
ant(4΄)-Ia (72%). All the isolates were PVL negative. S. 
aureus ST45 was previously identified in Iran [1], 
Netherlands [17], Switzerland [18], and Croatia [19]. 
This high prevalence of ST45 isolates in our study may 
be attributed to high transmissibility and rapidity of its 
spread within the community and/or increase in the 
volumes of international travel. 
According to the literature, ST239 have evolved 
from ST8 and ST30 parents and accounts for at least 
90% of hospital-acquired-MRSA in the South 
American, Europe, and some other Asian countries, 
including Kuwait, Saudi Arabia and Malaysia 
[3,16,20,21]. In the present study, multi resistant ST239 
was the second most common type identified (27.4%), 
although at a low level. Our previous study from Iran, 
carried out to identify molecular characteristics of 
MRSA isolated from blood samples, showed that 
ST239 was the most predominant type (43%). In line 
with the studies conducted by Abimanyu et al. in India 
[22] and Udo et al. in Kuwait [20], who demonstrated 
that HLMUPR-MRSA strains belonged to ST239 
clone, our findings showed that 12 HLMUPR-MRSA 
strains (14.3%) and 5 HLMUPR-MRSA strains (5.9%) 
belonged to ST239. Among our ST239 isolates, 12 
(14.3%), 3 (3.6%), and 2 isolates (2.4%) were positive 
for tst, eta and etb genes, respectively. S. aureus ST239, 
harboring tst, eta, and etb genes, has been detected Iran 
[1], Korea [23], Taiwan [3], and Kuwait [20], as well. 
As our results showed, ST585, as a single-locus 
variant (SLV) of ST239, was the third most-common 
type among the MRSA strains isolated from BSI 
(21.4%). Low frequency of this type has previously 
been reported [1,24]. In our previous research on 
MRSA strains isolated from BSI, ST585 was detected 
in 10.9% of tested isolates [1], which was lower than 
the rate found in the present study. Ohadian 
Moghadamet et al. [24], in Iran, identified molecular 
characterization of MRSA isolates obtained from 
clinical samples. They found that MRSA isolates 
belonged to two major clonal complexes (CC); CC8 
(ST239, ST585, ST2732, ST1294) and CC30 (ST30, 
ST36, ST1163) and the presence of ST585 was reported 
in 11.1% of the tested MRSA isolates. With regard to 
ST858 antibiotic resistance to gentamicin, tetracycline, 
and ciprofloxacin pattern, our findings support the 
recent study conducted by Goudarzi et al. [1]. 
Moreover, ST22 was the fourth most-common type 
identified in the current research (17.8%). This type was 
associated with a LLMUPR pattern (13.1%), and less 
than half of these strains carried the resistance genes 
tetM (7; 46.7), ermA (6; 40), msrB (5; 33.3), ermB (4; 
26.7), ermC [3;20], and ant(4΄)-Ia (1; 6.7). Variable 
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virulence markers in ST22-MRSA-IV have reported by 
investigators [20]. In the present study, 60% of ST22 
strains harbored the pvl gene. S. aureus ST22 harboring 
pvl gene was previously detected in Saudi Arabia [25], 
Iran [5,9], Kuwait [26], and England [27], too.  
Another type found among our strains was ST59. In 
contrast to a previous study in Taiwan [3], which 
reported a rate of 17.2% for ST59 strains isolated from 
blood, in the present study, we found low frequency of 
ST59 (3.6%), which all were positive for pvl encoding 
genes. Although antimicrobial resistance pattern in 
ST59 isolates may vary, we found that all the isolates 
were resistant to ciprofloxacin, tetracycline, and 
gentamicin. These findings, with regards to resistance 
to tetracycline, resembled those of the previous reports 
by Wang et al. [3] in Taiwan and Coombs et al. in 
Western Australia [28]. To the best of our knowledge, 
it is the first report of ST59 in MRSA strains isolated 
from patients with BSI in Iran. Given the wide 
dissemination of clonal complex 59 (CC59)/ST59 in the 
Asia Pacific region, it is guessed that transmission of 
these isolates may occur, due to the rate of 
transportation between these countries. 
 
Conclusion 
In conclusion, the present survey showed that 
MRSA isolated from blood has genetic diversity, 
including Five STs with different toxin and resistance 
gene profiles which should seriously be taken into 
consideration. ST59 was reported for the first time in 
Iran, indicating the emergence of the new ST in our 
region. Further and periodical studies are needed to 
delineate the genetic changes in MRSA isolated from 
blood.  
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